REFERENCES
M. Eichelbaum, G. von Unruh, and A. Somogyi. Application of stable labeled drugs in clinical pharmacokinetic investigations. Clin. Pharmacokinet. 7:490–507 (1982).
A. Jorgensen, In J. W. Bridges and L.F. Chasseaud (eds.), Progress in Drug Metabolism. Taylor and Francis, London and Philadelphia, 1986 pp. 111–174.
K. Midha, J. Hubbard, S. Marder, B. Marshall, and T. Van Putten. Impact of Clinical Pharmacokinetics on Neuroleptic Therapy in Schizophrenic Patients. J. Psychiatry Neurosci. 19:254–364 (1994).
M. S. Sardessai, M. J. Brander, K. K. Midha, and E. M. Hawes. Synthesis of deuterium labeled fluphenazine utilizing borane reduction. J. Labelled Compd. Radiopharm. 23:317–327 (1986).
R. Edom, Ph.D. Thesis, University of Saskatchewan, Saskatoon, Sask, Canada (1990).
K. K. Midha, J. K. Cooper, Y. D. Lapierre, and J. W. Hubbard. Fluphenazine, trifluoperazine and perphenazine in vacutainers. Can. Med. Assoc. J. 124:263–265 (1981).
S. Hadad, R. Edom, G. McKay, E. M. Hawes, and K. K. Midha. Simultaneous measurement of fluphenazine and [2H4]fluphenazine in plasma using solids probe tandem mass spectrometry. Biol. Mass Spectrom. In press (1994).
K. Midha, E. Hawes, J. Hubbard, E. Korchinski, and G. McKay. Variation in the single dose pharmacokinetics of fluphenazine in psychiatric patients. Psychopharmacology 96:206–211 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hadad, S., Hubbard, J.W., McKay, G. et al. Evidence for the Lack of a Human Metabolic Isotope Effect of a Deuterium Analog of Fluphenazine. Pharm Res 12, 1388–1390 (1995). https://doi.org/10.1023/A:1016298329188
Issue Date:
DOI: https://doi.org/10.1023/A:1016298329188